Hoda Hatoum1, Pablo Maureira2, Scott Lilly3, Lakshmi Prasad Dasi4. 1. Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio. 2. Department of Cardiovascular Surgery, CHU de Nancy, Nancy, France. 3. Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio. 4. Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio. Electronic address: lakshmi.dasi@osumc.edu.
Abstract
OBJECTIVES: The aim of this study was to evaluate any potential leaflet washout benefits after bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction during TAVR (BASILICA) in transcatheter valve-in-valve (ViV) in the context of leaflet thrombosis. BACKGROUND: Leaflet thrombosis after transcatheter aortic valve replacement is secondary to flow stasis in both the sinus and neosinus. Strategies to improve washout and ameliorate neosinus and sinus flow velocities may have the potential to mitigate the occurrence of clinical and subclinical leaflet thrombosis. METHODS: A 23-mm Edwards SAPIEN 3 and a 26-mm Medtronic Evolut were deployed in a 23-mm transparent surgical aortic valve model before and after leaflet laceration. The valves were placed in the aortic position of a pulse duplicator flow loop. Particle image velocimetry was performed to quantify sinus flow hemodynamic status. A tracing fluorescent dye was injected to evaluate the number of cycles to washout in both regions of interest. RESULTS: The leaflet laceration procedure led to an increase in the velocities in the sinus and the neosinus by 50% for Evolut ViV and 61.9% for SAPIEN 3 ViV. In addition, leaflet laceration led to a reduction in overall cycles to washout in the neosinus by at least 56% with the Evolut and 54.5% with the SAPIEN 3 and in the sinus by at least 16.7% with the Evolut and 60.8% with the SAPIEN. CONCLUSIONS: Leaflet laceration using a BASILICA-type approach may hold the potential to mitigate neosinus and sinus flow stasis. Controlled in vivo trials are necessary to establish the potential benefit of BASILICA to reduce the occurrence of leaflet thrombosis.
OBJECTIVES: The aim of this study was to evaluate any potential leaflet washout benefits after bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction during TAVR (BASILICA) in transcatheter valve-in-valve (ViV) in the context of leaflet thrombosis. BACKGROUND:Leaflet thrombosis after transcatheter aortic valve replacement is secondary to flow stasis in both the sinus and neosinus. Strategies to improve washout and ameliorate neosinus and sinus flow velocities may have the potential to mitigate the occurrence of clinical and subclinical leaflet thrombosis. METHODS: A 23-mm Edwards SAPIEN 3 and a 26-mm Medtronic Evolut were deployed in a 23-mm transparent surgical aortic valve model before and after leaflet laceration. The valves were placed in the aortic position of a pulse duplicator flow loop. Particle image velocimetry was performed to quantify sinus flow hemodynamic status. A tracing fluorescent dye was injected to evaluate the number of cycles to washout in both regions of interest. RESULTS: The leaflet laceration procedure led to an increase in the velocities in the sinus and the neosinus by 50% for Evolut ViV and 61.9% for SAPIEN 3 ViV. In addition, leaflet laceration led to a reduction in overall cycles to washout in the neosinus by at least 56% with the Evolut and 54.5% with the SAPIEN 3 and in the sinus by at least 16.7% with the Evolut and 60.8% with the SAPIEN. CONCLUSIONS: Leaflet laceration using a BASILICA-type approach may hold the potential to mitigate neosinus and sinus flow stasis. Controlled in vivo trials are necessary to establish the potential benefit of BASILICA to reduce the occurrence of leaflet thrombosis.
Authors: Fernanda M Mangione; Tannas Jatene; Alexandra Gonçalves; Gregory A Fishbein; Richard N Mitchell; Marc P Pelletier; Tsuyoshi Kaneko; Pinak B Shah; Charles B Nyman; Douglas Shook; Ron Blankstein; Robert F Padera; Deepak L Bhatt Journal: JACC Cardiovasc Imaging Date: 2017-01
Authors: Tarun Chakravarty; Lars Søndergaard; John Friedman; Ole De Backer; Daniel Berman; Klaus F Kofoed; Hasan Jilaihawi; Takahiro Shiota; Yigal Abramowitz; Troels H Jørgensen; Tanya Rami; Sharjeel Israr; Gregory Fontana; Martina de Knegt; Andreas Fuchs; Patrick Lyden; Alfredo Trento; Deepak L Bhatt; Martin B Leon; Raj R Makkar Journal: Lancet Date: 2017-03-19 Impact factor: 79.321
Authors: John G Webb; Michael J Mack; Jonathon M White; Danny Dvir; Philipp Blanke; Howard C Herrmann; Jonathon Leipsic; Susheel K Kodali; Raj Makkar; D Craig Miller; Philippe Pibarot; Augusto Pichard; Lowell F Satler; Lars Svensson; Maria C Alu; Rakesh M Suri; Martin B Leon Journal: J Am Coll Cardiol Date: 2017-05-09 Impact factor: 24.094
Authors: Scott Goldman; Anson Cheung; Joseph E Bavaria; Michael R Petracek; Mark A Groh; Hartzell V Schaff Journal: J Thorac Cardiovasc Surg Date: 2016-11-18 Impact factor: 5.209
Authors: Hoda Hatoum; Shelley Gooden; Megan Heitkemper; Kevin M Blum; Jason Zakko; Martin Bocks; Tai Yi; Yen-Lin Wu; Yadong Wang; Christopher K Breuer; Lakshmi Prasad Dasi Journal: Ann Biomed Eng Date: 2020-02-12 Impact factor: 3.934
Authors: Jaffar M Khan; Adam B Greenbaum; Vasilis C Babaliaros; Danny Dvir; Mark Reisman; James M McCabe; Lowell Satler; Ron Waksman; Marvin H Eng; Gaetano Paone; Marcus Y Chen; Christopher G Bruce; Annette M Stine; Xin Tian; Toby Rogers; Robert J Lederman Journal: Circ Cardiovasc Interv Date: 2021-05-18 Impact factor: 6.546
Authors: Hoda Hatoum; Sunyoung Ahn; Scott Lilly; Pablo Maureira; Juan Crestanello; Vinod H Thourani; Lakshmi Prasad Dasi Journal: JTCVS Open Date: 2022-01-24
Authors: Hoda Hatoum; Milad Samaee; Janarthanan Sathananthan; Stephanie Sellers; Maximilian Kuetting; Scott M Lilly; Abdul R Ihdayhid; Philipp Blanke; Jonathon Leipsic; Vinod H Thourani; Lakshmi Prasad Dasi Journal: JTCVS Open Date: 2022-04-20